Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|May 28, 2020
Biological Difference Between Epstein-Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical ImpactValeria Ferla, Francesca Gaia Rossi, Maria Cecilia Goldaniga, et al.
Annals of Hematology|September 18, 2010
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL)Andrea Ferrario, Francesco Merli, Stefano Luminari, et al.
Plos One|May 10, 2019
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre studyNicola Stefano Fracchiolla, Mariarita Sciumè, Nicola Orofino, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemiaAlessandra Tedeschi, Francesca Ricci, Maria Cecilia Goldaniga, et al.
Clinical Case Reports|February 18, 2021
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurinMariarita Sciumè, Fabio Serpenti, Simona Muratori, et al.
Diagnostic Microbiology and Infectious Disease|October 14, 2025
Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severityPatrizia Bono, Alessandra Parisi, Elena Tagliaferri, et al.
Leukemia & Lymphoma|February 5, 2015
Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemiaAlessandra Tedeschi, Paola Picardi, Simone Ferrero, et al.
The Oncologist|April 4, 2019
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical PracticeAlessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, et al.
Haematologica|August 5, 2017
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphomaAlessandro Broccoli, Cinzia Pellegrini, Alice Di Rocco, et al.
Oncotarget|December 7, 2017
Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphomaCinzia Pellegrini, Alessandro Broccoli, Alessandro Pulsoni, et al.
Pageof 1